ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 57 filers reported holding ONCOCYTE CORP in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,300 | -35.0% | 10,000 | 0.0% | 0.00% | – |
| Q1 2023 | $3,540 | +10.3% | 10,000 | 0.0% | 0.00% | – |
| Q4 2022 | $3,210 | -54.1% | 10,000 | 0.0% | 0.00% | – |
| Q3 2022 | $7,000 | -22.2% | 10,000 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | -40.0% | 10,000 | 0.0% | 0.00% | – |
| Q1 2022 | $15,000 | +1400.0% | 10,000 | +3211.3% | 0.00% | – |
| Q3 2021 | $1,000 | – | 302 | +2057.1% | 0.00% | – |
| Q2 2020 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 14 | -99.7% | 0.00% | – |
| Q1 2017 | $24,000 | -14.3% | 4,014 | 0.0% | 0.00% | – |
| Q4 2016 | $28,000 | +40.0% | 4,014 | 0.0% | 0.00% | – |
| Q3 2016 | $20,000 | +42.9% | 4,014 | 0.0% | 0.00% | – |
| Q2 2016 | $14,000 | -22.2% | 4,014 | 0.0% | 0.00% | – |
| Q1 2016 | $18,000 | – | 4,014 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 719,282 | $2,359,245 | 0.35% |
| Defender Capital, LLC. | 114,520 | $357,302 | 0.13% |